Poor management of the trials pivotal in achieving FDA approval years ago, using sound dependent smartphones in noisy USA hospitals to record paediatric coughs are now capped off again by a sloppy performance. Shareholders ought feel outraged by this performance.
Sorry for Professor Abeyratne whose amazing technology has been mismanaged.
FOX
Ann: Results from Data Confirmation Study, page-166
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #